I. Breast cancer patients need to be concerned with blood resin levels. Blood resin is the sum of blood cholesterol, glycerine triester and lipids High lipid haematosis is the type of disease 2 in plasma with elevated levels of cholesterol and/or glycerine, “cholesterol” with “good” and “bad” points in blood resin High-density Protein Cholesterol (HDL-C) “good” cholesterol, HDL-C can transport excess cholesterol back to the liver decomposition LDL-C can transport cholesterol to the blood vessels and accumulate on the vascular walls, resulting in the sclerosis of anthiophage. Although bad, it is also the most important indicator of blood resin change. What are the consequences of the “bad” cholesterol of low-density protein cholesterol (LDL-C)3 and the sclerosis of arteryal porridges caused by high lipid haemasis? The “bad” cholesterol LDL-C is closely related to the sclerosis of the aneurystic porridge, which causes coronary heart disease when it occurs in the heart; when it occurs in the brain, brain incapacitation occurs. Breast cancer patients, in particular, are particularly concerned with the prevalence of haemoglobinic abnormalities.
II. What factors have caused haematological abnormalities in post-menopausal breast cancer? 1 Estrogen has a protective effect on the cardiovascular environment 1 Estrogen has reduced the role of LDL-C and TC and can also protect the cardiovascular environment through the effects of blood pressure and blood sugar 2 The significant decline in female post-menopausal estrogen levels has led to an abnormally high haemoglobin incidence in the country, where more than half of breast cancer patients are in a period of menopausal or menopause at the time of the onset of the disease The significant decrease in female post-menopausal hormone levels has led to a significant increase in the incidence of haemoglobin abnormality 3 The endocrine treatment of breast cancer causes a decrease in estrogen, resulting in loss of protection of haemoglobin, loss of protection of blood resin by estrogen control and loss of protection of blood resins 4 The current common endocrine treatment drugs are divided into three categories according to the mechanism of their effects The selective estrogen regulates and estrogens: In the case of aromatic aromatic anesthesia inhibitors: aromatic aromatic enzymes before the use of aromatic aromatic aromatics, 6 in the case of lysergic aromatic aroma, 6 in the case of the risk of haematoacular aroma, 5 in the case of aromatic anesthesia inhibitors and their classification 5 in the case of aromatic anesthesia inhibitors, and classification 5 in the case of aromatic anesthesia inhibitors, and classification 5 in the case of aromatic anesthesia inhibitors, the effect of aromatic anesthesia inhibitors on haematogens by disrupting male hormones by converting them to estrogens, and the treatment of aromatic aromatic aromic acidic aesthetics in the case of acousesis, it is recommended that the use of lysyl aromatic aromatic aromatic aesthetics is used to treat the aromatic aromatic aromatic aromatic aesthetics with the use of aromatic acant
III. Questions on blood resin testing 1. How do you identify hyperlipid haematosis? Since the increase in blubber itself is non-symptomatic and has very few signs, clinical signs alone do not allow for the detection of hyperlipid haemorrhagic disorders, and blood tests are generally required to determine which matters should be taken into account in blood resin testing. How do you understand your blood resin test? It’s not easy to see whether the hair cut in the test list is a gill or a tiara.
iv. Daily blood resin management for breast cancer patients 1; blood resin management for breast cancer patients – Lifestyle intervention: reasonable diets: cessation of smoking; maintenance of desired body quality or weight reduction; AID treatment for breast cancer patients after menopause 2; periodic testing of blood resin for high-risk patients; testing of an empty abdominal blood resin every 6 to 12 months; testing of an empty abdominal blood resin every 6 months for common patients; indicators of detection should include: total cholesterol (TC), triester glycerine (TG), low-density protein (LDL-C) and high-density protein (HDL-C) 3; management of blood resin for breast cancer patients – drug treatment, taking into account your clinical conditions and risk factors, and deciding whether or not to give you a treatment for the substance, bearing in mind the need to comply with medical instructions! 4. Attention during tumour patients ‘ new coronary pneumonia (COVID-19)
In conclusion, the prevalence of haemoglobin abnormalities among breast cancer patients and the risk of increased cardiovascular disease, as well as the need to pay particular attention to blood resin health The protective effects of estrogens on cardiovascular health The effect of estrogens on women is increased with age and the decline of estrogens, leading to reduced protection of blood resins The endocrinic treatment of breast cancer patients causes a decrease of estrogens, leading to loss of protection of blood resin The risk of haemoglobinic hypervascular disease is reduced for breast cancer patients, the use of aromatic enzymes inhibitants of the gillium has a smaller impact on blood resin
Breast cancer
